BusinessCognition Therapeutics Co-Founder and CSO Susan Catalano to Present at the Annual ASENT MeetingBy Nasdaq OMXMar 6, 2018, 7:04 PM UTC
BusinessWave Life Sciences and Takeda Form Global Strategic Collaboration to Advance Therapies for Central Nervous System DisordersBy Nasdaq OMXFeb 20, 2018, 12:01 PM UTC
BusinessVoyager Therapeutics and AbbVie Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative DiseasesBy Nasdaq OMXFeb 20, 2018, 12:01 PM UTC
BusinessCognition Therapeutics to Participate in Leerink Partners 7th Annual Global Healthcare ConferenceBy Nasdaq OMXFeb 12, 2018, 2:01 PM UTC
BusinessIndia Globalization's Hyalolex Shows Promise in Treating Patients with Alzheimer's Disease -- CFN MediaBy Nasdaq OMXFeb 8, 2018, 1:30 PM UTC
BusinessIndia Globalization Capital Inc. Engages CFN Media to Develop New Investor AudienceBy Nasdaq OMXJan 22, 2018, 5:50 PM UTC
BusinessCognition Therapeutics Co-Founder and CSO Susan Catalano to Present at Sachs Neuroscience Innovation ForumBy Nasdaq OMXJan 4, 2018, 1:05 PM UTC
BusinessStreetwise Reports Examines Promising 'Hot' Alzheimer's Market for Biotech with 'Novel' Drug CandidateBy Nasdaq OMXNov 23, 2017, 1:45 PM UTC
